Jiangsu Hengrui Medicine
600276.SS
#507
Rank
ยฃ30.86 B
Marketcap
ยฃ4.59
Share price
-5.09%
Change (1 day)
-7.09%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of June 2024 : ยฃ4.52 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company has ยฃ4.52 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$ยฃ4.60 B11.61%
2021-12-31$ยฃ4.12 B19.29%
2020-12-31$ยฃ3.45 B28.54%
2019-12-31$ยฃ2.69 B18.47%
2018-12-31$ยฃ2.27 B25.23%
2017-12-31$ยฃ1.81 B20.67%
2016-12-31$ยฃ1.50 B39.48%
2015-12-31$ยฃ1.07 B27.36%
2014-12-31$ยฃ0.84 B27.02%
2013-12-31$ยฃ0.66 B23.36%
2012-12-31$ยฃ0.53 B20.44%
2011-12-31$ยฃ0.44 B31.23%
2010-12-31$ยฃ0.34 B40.53%
2009-12-31$ยฃ0.24 B17.95%
2008-12-31$ยฃ0.20 B81.31%
2007-12-31$ยฃ0.11 B37.12%
2006-12-31$ยฃ82.88 M4.07%
2005-12-31$ยฃ79.64 M26.53%
2004-12-31$ยฃ62.94 M2.16%
2003-12-31$ยฃ61.61 M0.96%
2002-12-31$ยฃ61.03 M-3.38%
2001-12-31$ยฃ63.16 M